MaxCyte, Inc. Presents Data On Stable Cell Line Generation And Rapid, High Titer Production Of Antibodies And Proteins Using Flow Electroporation

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

MaxCyte®, Inc., the pioneer in scalable, high-performance cell transfection systems, will be presenting data demonstrating dramatic reductions in antibody development timelines by enabling large-scale transient gene expression directly within cells commonly used in commercial protein production. The presentation will be made at IBC’s 24th Annual Antibody Engineering and Therapeutics Meeting, held December 8-12, 2013 at the Hyatt Regency Huntington Beach Resort & Spa, CA.

Help employers find you! Check out all the jobs and post your resume.

Back to news